Article Sidebar
Article Details
Issue
Section
Articles
Copyright for articles published in this journal is retained by the journal.
Main Article Content
Comparative study of artesunate, ACTs and their combinants on the biochemical parameters of male guinea-pigs
Abstract
In this study, the effects of different doses of artesunate, artesunate/sulfadoxine/ pyrimethamine, artesunate/amodiaquine and their combinants (sulfadoxine/pyrimethamine and artesunate/
amodiaquine) on the biochemical parameters- alkaline phosphatase (ALP), total acid phosphatase (ACPT), prostatic acid phosphatase (ACPP), urea, creatinine, uric acid and total cholesterol of the male guinea-pig were investigated. Basal serum ACPP value was increased from 3.50 ± 0.42 to 4.75 ± 0.85 and 4.75 ± 0.48 IU/L by amodiaquine and sulfadoxine/pyrimethamine respectively at their subclinical
doses. These values were significant at p < 0.05. Furthermore, the agents caused no significant effects (p < 0.05) on serum ALP and ACPT. Artesunate/sulfadoxine/pyrimethamine significantly increased (p <
0.05) serum urea at the 3 doses, while the effects of artesunate and artesunate/amodiaquine were biphasic, decreasing basal serum urea level at lower doses and increasing at higher doses. However,
basal serum creatinine level was increased from 62.5 ± 6.7 to 89.8 ± 4.8 ìmol/L by sulfadoxine/pyrimethamine and decreased to 53.0 ± 0 ìmol/L by artesunate/amodiaquine at their subclinical doses, while the other agents caused no significant (p < 0.05) effects. Furthermore, control serum uric acid level was significantly decreased from 368.8 ± 10.0 to 318.3 ± 5.8, 306.0 ± 1.2 and 312.3 ± 2.6 mmol/L by artesunate, amodiaquine and artesunate/amodiaquine, after administration of half their clinical doses,
respectively. Total blood cholesterol was also significantly reduced from 2.43 ± 0.13 to 2.1 ± 0 and 1.9 ±0 mmol/L after administration of clinical doses of amodiaquine and artesinate/amodiaquine, respectively. These biochemical changes may be due to oxidative effects induced by these agents.
amodiaquine) on the biochemical parameters- alkaline phosphatase (ALP), total acid phosphatase (ACPT), prostatic acid phosphatase (ACPP), urea, creatinine, uric acid and total cholesterol of the male guinea-pig were investigated. Basal serum ACPP value was increased from 3.50 ± 0.42 to 4.75 ± 0.85 and 4.75 ± 0.48 IU/L by amodiaquine and sulfadoxine/pyrimethamine respectively at their subclinical
doses. These values were significant at p < 0.05. Furthermore, the agents caused no significant effects (p < 0.05) on serum ALP and ACPT. Artesunate/sulfadoxine/pyrimethamine significantly increased (p <
0.05) serum urea at the 3 doses, while the effects of artesunate and artesunate/amodiaquine were biphasic, decreasing basal serum urea level at lower doses and increasing at higher doses. However,
basal serum creatinine level was increased from 62.5 ± 6.7 to 89.8 ± 4.8 ìmol/L by sulfadoxine/pyrimethamine and decreased to 53.0 ± 0 ìmol/L by artesunate/amodiaquine at their subclinical doses, while the other agents caused no significant (p < 0.05) effects. Furthermore, control serum uric acid level was significantly decreased from 368.8 ± 10.0 to 318.3 ± 5.8, 306.0 ± 1.2 and 312.3 ± 2.6 mmol/L by artesunate, amodiaquine and artesunate/amodiaquine, after administration of half their clinical doses,
respectively. Total blood cholesterol was also significantly reduced from 2.43 ± 0.13 to 2.1 ± 0 and 1.9 ±0 mmol/L after administration of clinical doses of amodiaquine and artesinate/amodiaquine, respectively. These biochemical changes may be due to oxidative effects induced by these agents.
